Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study

Cited by (432)

Items 201–300 of 432

1. Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
   A Rónaszéki, Marco Alings, Kenneth Egstrup, Zbigniew A. Gaciong, Marián Hranai, Csaba Király, Mátyás Sereg, Wojciech Figatowski, Patrik Bondarov, Susanne A. Johansson et al. · 2011 · EP Europace
2. Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey
   James A. Reiffel, Carina Blomström‐Lundqvist, Giuseppe Boriani, Andreas Goette, Peter Russell Kowey, José Luís Merino, Jonathan Paul Piccini, Sanjeev V. Saksena, A. John Camm · 2023 · EP Europace
3. Overview of antiarrhythmic drug therapy for supraventricular tachycardia in children
   Carolina A. Escudero, Roxane R. Carr, Shubhayan Sanatani · 2013 · Progress in Pediatric Cardiology
4. Usefulness of Pharmacologic Conversion of Atrial Fibrillation During Dofetilide Loading Without the Need for Electrical Cardioversion to Predict Durable Response to Therapy
   Rohit Malhotra, Kenneth C. Bilchick, John Dimarco · 2013 · The American Journal of Cardiology
5. Changes in global electrical heterogeneity associated with dofetilide, quinidine, ranolazine, and verapamil
   Hans Friedrich Stabenau, Changyu Shen, Larisa G. Tereshchenko, Jonathan W. Waks · 2019 · Heart Rhythm
6. Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents
   Federico Guerra, Stefan Hans Hohnloser, Peter Russell Kowey, Harry J.G.M. Crijns, Etienne Aliot, David Radzik, Denis Roy, Stuart J. Connolly, Alessandro Capucci · 2014 · Clinical Cardiology
7. Management of Atrial Fibrillation
   Payman L. Zamani, Ralph J. Verdino · 2014 · Journal of Intensive Care Medicine
8. Practitioner Acceptance of the Dofetilide Risk‐Management Program
   Nancy M. Allen LaPointe, Judith M. Kramer, Kevin P. Weinfurt, Robert M. Califf · 2002 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
9. Celivarone for Maintenance of Sinus Rhythm and Conversion of Atrial Fibrillation/Flutter
   Avinash Khitri, Etienne Aliot, Alessandro Capucci, Stuart J. Connolly, Harry J.G.M. Crijns, Stefan Hans Hohnloser, Piotr Kułakowski, Denis Roy, David Radzik, Peter R. Kowey · 2011 · Journal of Cardiovascular Electrophysiology
10. Overview of the Management of Atrial Fibrillation:
    Peter Russell Kowey, Gan‐Xin Yan, Tara L. Dimino, Dusan Z. Kocovic · 2003 · Journal of Cardiovascular Electrophysiology
11. What niche will newer class III antiarrhythmic drugs occupy?
    Bramah N. Singh, Jonnalagedda S.M. Sarma · 2001 · Current Cardiology Reports
12. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation
    Vera H.M. Deneer, Marieke B.I. Borgh, Jan Herre Kingma, Loraine Lie‐A‐Huen, J. R. B. J. Brouwers · 2004 · Pharmacy World & Science
13. Cardiac Arrhythmias 2005
    Antonio Raviele · 2006 · Springer eBooks
14. Safety of rapid switching from amiodarone to dofetilide in atrial fibrillation patients with an implantable cardioverter–defibrillator
    Sharan Prakash Sharma, Mohit K. Turagam, Donita Atkins, Sudha Bommana, Courtney Jeffrey, Diana Newton, Cheri Nydegger, Heidi Carroll, Rakesh Gopinathannair, Andrea Natale et al. · 2019 · Heart Rhythm
15. Drug Discovery vs hERG
    Derek J. Leishman, Zoran Ranković · 2014 · Topics in medicinal chemistry
16. Antiarrhythmic Drug Therapy for Atrial Fibrillation
    Muhammad Rizwan Sardar, Wajeeha Saeed, Peter Russell Kowey · 2014 · Cardiology Clinics
17. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation
    Niyada Naksuk, Alan M. Sugrue, Deepak Padmanabhan, Danesh Kella, Christopher V. DeSimone, Suraj Kapa, Samuel J. Asirvatham, Hon-Chi Lee, Michael John Ackerman, Peter A. Noseworthy · 2018 · Journal of Interventional Cardiac Electrophysiology
18. Antiarrhythmic drug therapy of atrial fibrillation
    Robert A. Vernooy, John Paul Mounsey · 2004 · Cardiology Clinics
19. Cardioversion of Atrial Fibrillation
    Subhashini A. Gowda, Arti N. Shah, Jonathan S. Steinberg · 2005 · Progress in Cardiovascular Diseases
20. Observations on the Safety and Effectiveness of Dofetilide in Patients With Paroxysmal Atrial Fibrillation and Normal Left Ventricular Function
    Andrew Mykytsey, Jerry L. Bauman, Mansour Razminia, Terry A. Zheutlin, Ted Wang, Mohammad Saleem, Sergio Leal, Richard Kehoe · 2007 · Journal of Cardiovascular Pharmacology and Therapeutics
21. Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepository
    Jason I. Koontz, Daniel B. Haithcock, Valerie Cumbea, Anthony Waldron, Kristie Stricker, Amy Hughes, Kent Ronald Nilsson, Albert Sun, Jonathan Paul Piccini, William E. Kraus et al. · 2009 · American Heart Journal
22. Atrial Fibrillation: Pharmacological Therapy
    Chinmay Patel, Mohammed Salahuddin, Andria Jones, Aashay Patel, Gan‐Xin Yan, Peter Russell Kowey · 2011 · Current Problems in Cardiology
23. A New Class III Antiarrhythmic Drug Niferidil Prolongs Action Potentials in Guinea Pig Atrial Myocardium via Inhibition of Rapid Delayed Rectifier
    Абрамочкин Денис Валерьевич, V. S. Kuzmin, Leonid V. Rosenshtraukh · 2017 · Cardiovascular Drugs and Therapy
24. Current Management of Symptomatic Atrial Fibrillation
    Kevin Stephen Channer · 2001 · Drugs
25. Advances in the acute pharmacologic management of cardiac arrhythmias
    Andrea Sarkozy, Paul Dorian · 2003 · Current Cardiology Reports
26. Drug Therapy for Atrial Fibrillation
    Simone Musco, Emily L. Conway, Peter Russell Kowey · 2007 · Medical Clinics of North America
27. Practice variation in the re-initiation of dofetilide: An observational study
    Mohit K. Turagam, Muhammad R. Afzal, Madhu Reddy, Jayasree Pillarisetti, Madhav Lavu, Donita Atkins, Courtney Jeffrey, Katie Christensen, Rhea Pimentel, Raghuveer Dendi et al. · 2017 · International Journal of Cardiology
28. Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction
    Chien‐Yu Huang, Brian R. Overholser, Kevin M. Sowinski, Heather A. Jaynes, Richard J. Kovacs, James Edward Tisdale · 2024 · PLoS ONE
29. Prescribers' Practice of Assessing Arrhythmia Risk with QT ‐Prolonging Medications
    Wai Kah Choo, David Turpie, Kim Milne, Lynne Davidson, Petrus Elofuke, Jonathan P Whitfield, Paul Broadhurst · 2014 · Cardiovascular Therapeutics
30. Pharmacokinetics and Pharmacodynamics: The Role of Sex and Gender
    Flavia Franconi, Manuela Sanna, Elisabetta Straface, Roberto Chessa, Giuseppe M.C. Rosano · 2011 · Springer eBooks
31. Treating Cardiac Arrhythmias Detected With an Implantable Cardiac Monitor in Patients After an Acute Myocardial Infarction
    Christian Jøns, Poul Erik Bloch Thomsen · 2011 · Current Treatment Options in Cardiovascular Medicine
32. Atrial Fibrillation: Antiarrhythmic Therapy
    Mitchell A. Psotka, Byron Kwock Lee · 2014 · Current Problems in Cardiology
33. Comparison of the effects of IK,ACh, IKr, and INa block in conscious dogs with atrial fibrillation and on action potentials in remodeled atrial trabeculae
    Viktor Juhász, Tibor Hornyik, A Benak, Norbert Nagy, Zoltán Husti, Róbert Pap, László Sághy, László Virág, András Varró, István Baczkó · 2017 · Canadian Journal of Physiology and Pharmacology
34. Management of tachyarrhythmias in pregnancy – A review
    Priyanka Kugamoorthy, DANNA A. SPEARS · 2020 · Obstetric Medicine
35. Antiarrhythmic Medications
    J. Anthony Gomes · 2020 · Springer eBooks
36. Atrial Fibrillation After Cardiac Surgery: Pathophysiology and Treatment
    Christopher A. Palin, Kailasam Rajagopal, Charles W. Jr Hogue · 2004 · Seminars in Cardiothoracic and Vascular Anesthesia
37. Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure
    Jayanthi N. Koneru, Jonathan S. Steinberg · 2008 · Current Opinion in Cardiology
38. Atrial fibrillation: Choosing an antiarrhythmic drug
    Todd J. Rudo, Peter Russell Kowey · 2006 · Current Cardiology Reports
39. Effects of Azimilide on the Muscarinic Acetylcholine Receptor-Operated K+ Current and Experimental Atrial Fibrillation in Guinea-Pig Hearts
    Atsushi Nishida, Yoshie Reien, Takehiko Ogura, Hiroko Uemura, Masaji Tamagawa, Hideo Yabana, Haruaki Nakaya · 2007 · Journal of Pharmacological Sciences
40. Antiarrhythmic drug therapy: what is certain and what is to come
    Alessandro Capucci · 2003 · European Heart Journal Supplements
41. Tedisamil: a new novel antiarrhythmic
    Bethan Freestone, Gregory Y.H. Lip · 2004 · Expert Opinion on Investigational Drugs
42. Impact of a Pharmacy-Cardiology Collaborative Practice on Dofetilide Safety Monitoring
    Lieth H. Quffa, Mark Edward Panna, Michael R. Kaufmann, Matthew McKillop, Nicole Maltese, Andrew J. Franck · 2016 · Annals of Pharmacotherapy
43. Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator
    Ryan J. Koene, Vivek Menon, Daniel J. Cantillon, Thomas Dresing, David O. Martin, Mohamed Hani Kanj, Walid I. Saliba, Khaldoun G. Tarakji, Bryan J. Baranowski, Ayman Ali Hussein et al. · 2020 · Circulation Arrhythmia and Electrophysiology
44. Effect of dofetilide on the pharmacokinetics of digoxin
    Diane Kleinermans, Donald J. Nichols, Isobel Dalrymple · 2001 · The American Journal of Cardiology
45. Drug Therapy for Atrial Fibrillation
    Emily L. Conway, Simone Musco, Peter Russell Kowey · 2008 · Cardiology Clinics
46. Pharmacotherapy of Atrial Fibrillation: A Pathophysiological Perspective and Review
    Sony Jacob, Omaima A. Ali, Victoria Pidlaoan, Apurva Omkar Badheka, Nicholas Z. Kerin · 2010 · American Journal of Therapeutics
47. Current Concepts and Management Strategies in Atrial Flutter
    Sunil Kumar Dhar, Pooja Lidhoo, Deepak Koul, Sanjay Dhar, Manvendra Bakhshi, Florin T. Deger · 2009 · Southern Medical Journal
48. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis
    Kishore Kukendrarajah, Mahmood Ahmad, M Carrington, Adam Ioannou, Julie Taylor, Yousuf Razvi, Νικόλαος Παπαγεωργίου, Gillian Elizabeth Mead, Immaculate Nevis, Fabrizio D’Ascenzo et al. · 2024 · Cochrane Database of Systematic Reviews
49. Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias
    Demosthenes G. Katritsis, Giuseppe Boriani, Francisco G. Cosío, Pierre Jaı̈s, Gerhard Hindricks, Mark E. Josephson, Roberto Keegan, Bradley P. Knight, Karl‐Heinz Kück, Deirdre A. Lane et al. · 2016 · Arrhythmia & Electrophysiology Review
50. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center
    Clara Ting, Rhynn J. Malloy, Danielle M. Knowles · 2020 · Journal of Cardiovascular Pharmacology and Therapeutics
51. Enhanced Response to Drug-Induced QT Interval Lengthening in Patients with Heart Failure with Preserved Ejection Fraction
    James Edward Tisdale, Heather A. Jaynes, Brian R. Overholser, Kevin M. Sowinski, Mark D. Fisch, Jo E. Rodgers, Ahmed Mohammed Aldemerdash, Chia‐Chi Hsu, Nan Wang, Elena Tomaselli Muensterman et al. · 2020 · Journal of Cardiac Failure
52. Coronary Artery Disease Potentiates Response to Dofetilide for Rhythm Control of Atrial Fibrillation
    Pankaj Manocha, Venkata V. Bavikati, Jonathan J. Langberg, Michael Shane Lloyd · 2011 · Pacing and Clinical Electrophysiology
53. Pharmacotherapeutic decision-making for patients with atrial fibrillation
    James S. Kalus · 2010 · American Journal of Health-System Pharmacy
54. Atrial fibrillation: advances and perspectives
    A. John Camm, Irina Savelieva · 2003
55. Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions
    Alex F. Grubb, Robert John Mentz · 2020 · Expert Review of Cardiovascular Therapy
56. Contemporary Approach to Electrical and Pharmacological Cardioversion of Atrial Fibrillation
    Bharath Rajagopalan, Anne B. Curtis · 2012 · Postgraduate Medicine
57. Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
    Amy Wang · 2012 · Pharmacy Practice
58. Late dofetilide-associated life-threatening proarrhythmia
    Christof Kolb, Gjin Ndrepepa, Bernhard Zrenner · 2007 · International Journal of Cardiology
59. Effects of Azimilide on Heart Rate and ECG Conduction Intervals during Sinus Rhythm in Patients with a History of Atrial Fibrillation
    Edward L.C. Pritchett, Marcia C. Schulte, Daniel Schnell, Stephen R. Marcello, William E. Wilkinson, Richard L. Page, Stuart J. Connolly · 2002 · The Journal of Clinical Pharmacology
60. Electrophysiologic Mechanism of Typical Atrial Flutter Termination by Nifekalant: Effect of a Pure IKr‐Selective Blocking Agent
    Hiroshige Yamabe, Yasuaki Tanaka, Kenji Morihisa, Takashi Uemura, Junjiroh Koyama, Hisanori Kanazawa, Tadashi Hoshiyama, Hisao Ogawa · 2013 · Pacing and Clinical Electrophysiology
61. Short‐ and long‐term clinical predictors of pharmacological cardioversion of persistent atrial fibrillation by dofetilide: A retrospective cohort study of 160 patients
    Hafeez Ul Hassan Virk, Waqas Qureshi, Nayani Makkar, Joseph Bastawrose, Nektarios Souvaliotis, Joshua Aziz, Emad F. Aziz · 2017 · Clinical Cardiology
62. Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival
    Shaan S. Khurshid, Simon Akerman, Jonathan P. Man, Gregory E. Supple, Sanjay Dixit, Andrew E. Epstein, Francis E. Marchlinski, David S. Frankel · 2015 · Journal of Interventional Cardiac Electrophysiology
63. Pharmacokinetics/Pharmacodynamics of Antiarrhythmic Drugs
    Julia H. Indik, Raymond L. Woosley · 2010 · Cardiac Electrophysiology Clinics
64. Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation
    Henry Darchon Huang, Jonathan W. Waks, Daniel A. Steinhaus, PETER J. ZIMETBAUM · 2016 · Heart Rhythm
65. Dofetilide-Associated QT Prolongation: Total Body Weight Versus Adjusted or Ideal Body Weight for Dosing
    Stephen Y. Wang, Terrence D. Welch, Rajbir S. Sangha, Robert Maloney, Zhu Cui, Aaron V. Kaplan · 2018 · Journal of Cardiovascular Pharmacology
66. Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.
    Hassan Of, Jassim M. S. Al Suwaidi, Amar Mohammad Salam · 2013 · Europe PMC (PubMed Central)
67. Dofetilide Initiation and Implications of Deviation From the Standard Protocol – A Real World Experience
    Tawseef Ahmad Dar, Ghulam Murtaza, Bharath Yarlagadda, Bader Madoukh, Lesley Bravin, Venkat Lakshmi Kishan Vuddanda, Valay K. Parikh, Madhu Reddy, Dhanunjaya Lakkireddy · 2019 · Journal of Atrial Fibrillation
68. Atrial Fibrillation
    Eric Goralnick, Laura J. Bontempo · 2015 · Emergency Medicine Clinics of North America
69. Ibutilide in Rapid Conversion of Atrial Flutter in Octogenarians
    Roberto Antonicelli, Paolo Testarmata, Andrea Recanatini · 2002 · Drugs & Aging
70. Atrial fibrillation and cardiac surgery
    Sarah A McMurry, Charles W. Jr Hogue · 2004 · Current Opinion in Anaesthesiology
71. Antiarrhythmic drugs: new agents and evolving concepts
    Jan Němec, Win-Kuang Shen · 2003 · Expert Opinion on Investigational Drugs
72. Atrial flutter
    Ashok Kumar Garg, Gregory K. Feld · 2001 · Current Treatment Options in Cardiovascular Medicine
73. Cardiac Arrhythmias and Pregnancy
    DANNA A. SPEARS, Uri Elkayam · 2019 · Wiley eBooks
74. Electrocardiographic Markers of Repolarization Heterogeneity During Dofetilide or Sotalol Initiation for Paroxysmal Atrial Fibrillation
    Andrew J. Sauer, Rachel M. Kaplan, Joel Q. Xue, Pat Dorsey, Matthew Hayes, Sanjiv Jayendra Shah, ROD S. PASSMAN · 2014 · The American Journal of Cardiology
75. Neurological complications of cardiovascular drugs
    Michael A. Kelly · 2021 · Handbook of clinical neurology
76. Selection of Drugs in Pursuit of a Rhythm Control Strategy
    Peter Russell Kowey, Mathias L. Stoenescu · 2005 · Progress in Cardiovascular Diseases
77. Atrial Fibrillation and Stroke: The Evolving Role of Rhythm Control
    Taral K. Patel, ROD S. PASSMAN · 2013 · Current Treatment Options in Cardiovascular Medicine
78. Electrical and Pharmacologic Cardioversion for Atrial Fibrillation
    Susan S. Kim, Bradley P. Knight · 2007 · Medical Clinics of North America
79. Antiarrhythmic drugs for atrial fibrillation
    Alessandro Marinelli, Alessandro Capucci · 2011 · Expert Opinion on Pharmacotherapy
80. Rhythm Association and the Heart Rhythm Society Developed in Collaboration With the European Heart Atrial Fibrillation): Committee to Revise the 2001 Guidelines for the Management of Patients With the European Society of Cardiology Committee for Practice Guidelines (Writing Cardiology/American Heart Association Task Force on Practice Guidelines and Fibrillation—Executive Summary: A Report of the American College of ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial
    João Morais, Ady Osterspey, Juan Luis Tamargo, Luis Zamorano, Catherine Despres, Kenneth Dickstein, John P Lekakis, Keith McGregor, Marco Metra, Andrzej Budaj et al. · 2006
81. Atrial Fibrillation in the Heart Failure Population
    Carol A. Offutt · 2004 · The Journal of Cardiovascular Nursing
82. Cavotricuspid Isthmus-Dependent Atrial Flutter. Beyond Simple Linear Ablation
    Julián Abdala Lizarraga, Javier Quesada-Ocete, Blanca Quesada-Ocete, Javier Jiménez-Bello, Aurelio Quesada · 2024 · Reviews in Cardiovascular Medicine
83. Mechanisms of Chemical Atrial Defibrillation by Flecainide and Ibutilide
    Pei‐Chi Yang, Luiz Belardinelli, Colleen E. Clancy · 2024 · JACC. Clinical electrophysiology
84. Safety of dofetilide in stable patients and investigating traits of susceptibility to torsade de pointes
    Maria Cecilia Tagle-Cornell, Chadi Ayoub, Christen W. Bird, Milagros Pereyra, Courtney R. Kenyon, Moaz Kamel, Shruti Krishna Iyengar, Hema Srikanth Vemulapalli, Francesca I. Galasso, Marlene E Girardo et al. · 2024 · IJC Heart & Vasculature
85. Dofetilide induced trigeminal neuralgia
    Hayan Al Maluli · 2015 · Indian Journal of Pharmacology
86. Current Approaches to Antiarrhythmic Therapy in Heart Failure
    Lisa J. Rose‐Jones, Weeranun Dechyapirom Bode, Anil K. Gehi · 2014 · Heart Failure Clinics
87. Atrial fibrillation management: evaluating rate vs rhythm control
    Tuan L. Nguyen, Umjeet Singh Jolly, Kiran Sidhu, Raymond K. Yee, Peter Leong‐Sit · 2016 · Expert Review of Cardiovascular Therapy
88. Clinical Pearls in Using Antiarrhythmic Drugs in the Outpatient Setting
    Mary H. Parker, Cynthia A. Sanoski · 2015 · Journal of Pharmacy Practice
89. Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?
    Jem D. Lane, Andrew Tinker · 2017 · Frontiers in Physiology
90. Class III Antiarrhythmic Drugs
    Juan Luis Tamargo, Ricardo Caballero, Eva Delpón · 2020 · Springer eBooks
91. Development of a Care Pathway for Atrial Fibrillation Patients in the Emergency Department
    Duc H. Do, Breno Bernardes‐Souza, Michael Merjanian, Brandan Lombardo, David M. Donaldson, Lynnell B. McCullough, Noel G. Boyle, Richelle J. Cooper · 2022 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
92. Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation
    P CHANDRA · 2004 · EP Europace
93. Nuevos conceptos en el tratamiento de la fibrilación auricular
    Blanca Coll-Vinent Puig, Miquel Sánchez Sánchez, Lluı́s Mont · 2001 · Medicina Clínica
94. Pure Class III Agents for Prevention of Sudden Cardiac Death
    Craig M. Pratt · 2003 · Journal of Cardiovascular Electrophysiology
95. Dofetilide Reloaded
    David Felipe Briceno, Gregory E. Supple · 2017 · Circulation Arrhythmia and Electrophysiology
96. Arrhythmias in Patients With Heart Failure Prescribed Dofetilide or Sotalol
    Chien‐Yu Huang, Brian R. Overholser, Kevin M. Sowinski, Heather A. Jaynes, Richard J. Kovacs, James Edward Tisdale · 2024 · JACC Advances
97. Management Strategies in Atrial Fibrillation in Patients With Heart Failure
    Amir Y. Shaikh, Abhishek Maan, Edwin Kevin Heist, Dennis A. Tighe, Gerard P. Aurigemma, David D. McManus · 2012 · Cardiology in Review
98. Arrhythmias
    Jordi Heijman, Dobromir Dobrev · 2021 · Elsevier eBooks
99. Management of atrial fibrillation: What is new in the 2014 ACC/AHA/HRS guideline?
    Bharath Rajagopalan, Anne B. Curtis · 2015 · Postgraduate Medicine
100. Evaluation of initial dofetilide dosing recommendation based on actual body weight in overweight and obese patients
     D. X. Cao, A. Kohatsu, L. Eng, K. Mei, J. Dinh, I. Mok, N. Moreau, Ann Le, J. Shin · 2015 · Journal of Clinical Pharmacy and Therapeutics